In the liver, this process contributes to progression of NAFLD and transition to NASH, categorized by liver steatosis, hepatocyte degeneration, hepatic insulin resistance and the onset of hepatic fibrosis3. Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.